Lebanon vs Mozambique: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Lebanon
67.0%
in 2025
Mozambique
70.0%
in 2025
Lebanon rank
137th
Mozambique rank
134th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Lebanon
- Mozambique
How they compare
Mozambique currently reports 70.0% against 67.0% in Lebanon, a difference of 3.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Mozambique ahead.
Lebanon ranks 137th and Mozambique ranks 134th of 194 countries.
Across the 3 decades both report, Lebanon averaged higher in 1 and Mozambique in 1.
Head to head by decade
| Decade | Lebanon | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 24.6% | 52.1% | 27.5% | Mozambique |
| 2020s | 68.2% | 64.8% | 3.3% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Lebanon or Mozambique?
- Mozambique, at 70.0% against 67.0% in Lebanon as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Lebanon and Mozambique?
- 3.0%, with Mozambique ahead.
- How many years of comparable data are there for Lebanon and Mozambique?
- 18 years are reported by both, from 2008 to 2025.
- How do Lebanon and Mozambique rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Lebanon ranks 137th and Mozambique ranks 134th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.